CSIMarket
 


Globus Medical Inc   (GMED)
Other Ticker:  
 
 

GMED's Net Income Growth by Quarter and Year

Globus Medical Inc 's Net Income results by quarter and year




GMED Net Income (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - 15.03 50.06 15.11
III Quarter September - 1.00 47.43 47.21
II Quarter June 31.76 57.71 54.59 41.55
I Quarter March -7.12 49.13 38.08 45.33
FY   24.64 122.87 190.16 149.20



GMED Net Income second quarter 2024 Y/Y Growth Comment
Globus Medical Inc reported fall in Net Income in the second quarter 2024 by -44.97% to $ 31.76 millions, from the same quarter in 2023.
The drop in the second quarter 2024 Globus Medical Inc 's Net Income compares unfavorably to the Company's average Net Income growth of 8.34%.

Looking into second quarter 2024 results within Medical Equipment & Supplies industry 20 other companies have achieved higher Net Income growth. While Globus Medical Inc ' s Net Income drop of -44.97% ranks overall at the positon no. 726 in the second quarter 2024.




GMED Net Income ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December - -69.98 % 231.3 % -71.47 %
III Quarter September - -97.89 % 0.47 % 6.76 %
II Quarter June -44.97 % 5.72 % 31.38 % -
I Quarter March - 29.02 % -15.99 % 74.68 %
FY   - -35.39 % 27.45 % 45.86 %

Financial Statements
Globus Medical Inc 's second quarter 2024 Net Income $ 31.76 millions GMED's Income Statement
Globus Medical Inc 's second quarter 2023 Net Income $ 57.71 millions Quarterly GMED's Income Statement


GMED Net Income (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December - 1403 % 5.55 % -67.99 %
III Quarter September - -98.27 % -13.12 % 13.62 %
II Quarter June - 17.46 % 43.36 % -8.34 %
I Quarter March - -1.86 % 152.02 % -14.41 %
FY (Year on Year)   - -35.39 % 27.45 % 45.86 %




Net Income second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #21
Healthcare Sector #58
Overall #726

Net Income Y/Y Growth Statistics
High Average Low
106.91 % 8.34 % -80.09 %
(Jun 30 2021)   (Jun 30 2024)
Net Income second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #21
Healthcare Sector #58
Overall #726
Net Income Y/Y Growth Statistics
High Average Low
106.91 % 8.34 % -80.09 %
(Jun 30 2021)   (Jun 30 2024)

Net Income by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Globus Medical Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


GMED's II. Quarter Q/Q Net Income Comment
II. Quarter 2024Seasonal Globus Medical Inc in the factors net loss of $ 31.76 millionsSeasonal factors seem to have led to Globus Medical Inc 's restoration of positive trends, as GMED deliverNet Income of $ 31.76 millions in the II. Quarter 2024 coming of net loss-7.12 millions in the first quarter. Globus Medical Inc announced in the II. Quarter 2024 Net Income of $ 31.76 millions compare to net loss recorded in previos quarter.

Within Medical Equipment & Supplies industry Globus Medical Inc achieved highest sequential Net Income growth. While Globus Medical Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


GMED's II. Quarter Q/Q Net Income Comment
II. Quarter 2024Cyclical Globus Medical Inc in the influence net loss of $ 31.76 millionsCyclical influence seem to have contributed Globus Medical Inc 's restoration of recovery, as GMED postNet Income of $ 31.76 millions in the II. Quarter 2024 emerging from net loss-7.12 millions in the first quarter. Globus Medical Inc announced in the II. Quarter 2024 Net Income of $ 31.76 millions compare to net loss recorded in previos quarter.

Within Medical Equipment & Supplies industry Globus Medical Inc achieved highest sequential Net Income growth. While Globus Medical Inc 's Net Income growth quarter on quarter, overall rank is .


Globus Medical Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Jun 30 2024)
12 Months Ending
(Mar 31 2024)
12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
Cumulative Net Income 12 Months Ending $ 40.68 $ 66.63 $ 122.87 $ 157.90 $ 204.34
Y / Y Net Income Growth (TTM) -80.09 % -66.89 % -35.39 % 1.73 % 31.84 %
Year on Year Net Income Growth Overall Ranking # 384 # 372 # 232 # 1321 # 1395
Seqeuential Net Income Change (TTM) -38.95 % -45.78 % -22.18 % -22.72 % 1.55 %
Seq. Net Income Growth (TTM) Overall Ranking # 726 # 641 # 261 # 997 # 900


Cumulative Net Income growth Comment
Globus Medical Inc 's cumulative 12 months Net Income continue to drop, but on the faster rate at -80.09% year on year, at Jun 30 2024 compare to the -66.89% decrease at Mar 31 2024. If the Globus Medical Inc 's fiscal year would end at Jun 30 2024, annual Net Income would be $41 millions.

In the Healthcare sector 37 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 372 to 384.

Net Income TTM Q/Q Growth Statistics
High Average Low
106.91 %
8.34 %
-80.09 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 21
Healthcare Sector # 38
Overall # 384

Net Income TTM Y/Y Growth Statistics
High Average Low
106.91 %
8.34 %
-80.09 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 21
Sector # 58
S&P 500 # 726
Cumulative Net Income growth Comment
Globus Medical Inc 's cumulative 12 months Net Income continue to drop, but on the faster rate at -80.09% year on year, at Jun 30 2024 compare to the -66.89% decrease at Mar 31 2024. If the Globus Medical Inc 's fiscal year would end at Jun 30 2024, annual Net Income would be $41 millions.

In the Healthcare sector 37 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 372 to 384.

Net Income TTM Q/Q Growth Statistics
High Average Low
106.91 %
8.34 %
-80.09 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 21
Healthcare Sector # 38
Overall # 384

Net Income TTM Y/Y Growth Statistics
High Average Low
106.91 %
8.34 %
-80.09 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 21
Sector # 58
S&P 500 # 726




Other Net Income Growth
Medical Equipment & Supplies Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
GMED's Net Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for GMED's Competitors
Net Income Growth for Globus Medical Inc 's Suppliers
Net Income Growth for GMED's Customers

You may also want to know
GMED's Annual Growth Rates GMED's Profitability Ratios GMED's Asset Turnover Ratio GMED's Dividend Growth
GMED's Roe GMED's Valuation Ratios GMED's Financial Strength Ratios GMED's Dividend Payout Ratio
GMED's Roa GMED's Inventory Turnover Ratio GMED's Growth Rates GMED's Dividend Comparisons



Companies with similar Net Income drop for the quarter ending Jun 30 2024 within Healthcare SectorY/Y Change %Net Income for the quarter ending Jun 30 2024
Biogen Inc -1.63%$ -1.635 millions
Embecta Corp -3.29%$ -3.289 millions
Quest Diagnostics Inc-3.61%$ -3.614 millions
Abbott Laboratories-5.31%$ -5.309 millions
Zoetis Inc -6.87%$ -6.866 millions
Idexx Laboratories Inc-9.34%$ -9.337 millions
Prestige Consumer Healthcare Inc -11.89%$ -11.893 millions
Align Technology inc -13.64%$ -13.639 millions
National Research Corporation-15.10%$ -15.097 millions
Dariohealth Corp -17.94%$ -17.938 millions
Bristol myers Squibb Company-18.92%$ -18.922 millions
Organon and Co -19.42%$ -19.421 millions
U S Physical Therapy Inc-21.21%$ -21.206 millions
Fonar Corporation-25.01%$ -25.010 millions
Pacira Biosciences inc -26.69%$ -26.693 millions
Privia Health Group Inc -27.00%$ -26.997 millions
West Pharmaceutical Services Inc -28.24%$ -28.240 millions
Neurocrine Biosciences Inc -31.94%$ -31.937 millions
Abbvie Inc -32.26%$ -32.264 millions
Lifevantage Corp-33.62%$ -33.622 millions
Lantheus Holdings Inc -34.06%$ -34.057 millions
Viemed Healthcare Inc -36.61%$ -36.609 millions
Vaso Corporation-44.26%$ -44.257 millions
Nature s Sunshine Products inc -44.42%$ -44.415 millions
Royalty Pharma Plc-44.67%$ -44.675 millions
Globus Medical Inc -44.97%$ -44.968 millions
Amgen Inc -45.90%$ -45.903 millions
Elite Pharmaceuticals Inc -46.07%$ -46.070 millions
Surgery Partners Inc -50.78%$ -50.780 millions
Radnet Inc -52.29%$ -52.294 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com